Function Health, a membership-based platform that gives consumers access to more than 100 different lab tests, closed a Series A financing round that brought its total funding to date to $53 million. The round was led by Andreessen Horowitz and included a slew of celebrity investors, including Matt Damon, Zac Efron, Blake Griffin and Colin Kaepernick.
The FDA has asked for more information about cardiac complications reported last year in a Phase 1 study for the Molecular Templates cancer drug, MT-0169. The partial clinical hold comes as the biotech works through a corporate restructuring as well as a second Nasdaq de-listing notice.
ClosedLoop.ai, an Austin-based healthcare startup, raised new funding after being picked by CMS as the winner of its AI Health Outcomes Challenge. The company’s secret? Working with health systems to build algorithms that are explainable.
Wheel, an Austin-based telehealth startup, raised $50 million in series B funding. The company builds networks of clinicians behind several well-known digital health brands.
Austin-based software startup Docstation is working to make it easier for pharmacists to strike agreements with physicians that would allow them to provide more patient care. It recently raised $3.1 million in seed funding.
After a busy year, at-home testing company Everlywell is growing through two acquisitions. It bought telehealth practice PWNHealth and another at-home lab testing company.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
After Everlywell received an emergency use authorization last year from the FDA for its at-home collection kit, the agency gave Everlywell the green light to sell its test kits without requiring a prescription.
The Austin-based startup has distributed more than 500,000 Covid-19 test kits to date, and expects total sales to quadruple by the end of the year.
The company hopes to use the money to bring its T-cell antigen coupler cell therapy technology - currently in preclinical development - into human clinical trials. German drugmaker Bayer's venture capital arm led the round.
The company said consumers can order the test for $135 and submit samples to CLIA-certified labs, with physicians providing free telehealth consultations if they test positive.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
The device connects to a patient's smartphone, captures images and sends them to an orthodontist thereby taking the hassle of going to a dentist's office to straighten teeth among other things.
Last month, the Austin, Texas-based VC announced the close of their third fund, a $250 million fund that exceeded the company's initial $200 million goal.
With the new funding, MAP Health Management is hoping to more than double the states it operates in and move upstream to other sites of care to help treat substance abuse before it worsens.
Christiana Care Health System, Summation Health Ventures and the Texas Medical Center led the round, and HealthX Ventures and Cultivation Capital also participated.
Both Texas-based companies offer electronic health record solutions as well as other medical software and tools.